Pharmaceutical Contract Sales Organizations Market Scope And Analysis

  • Report Code : TIPRE00030074
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 221
Buy Now

Pharmaceutical Contract Sales Organizations Market Analysis, Scope, and Growth by 2030

Buy Now


Pharmaceutical Contract Sales Organizations Market Report Scope

Report Attribute Details
Market size in 2022 US$ 8.21 Billion
Market Size by 2030 US$ 15.82 Billion
Global CAGR (2022 - 2030) 8.6%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Services
  • Commercial Services and Non-Commercial Services
By Modules
  • Syndicated Modules and Dedicated Modules
By Therapeutic Area
  • Cardiovascular Disorders
  • Oncology
  • Metabolic Disorders
  • Neurology
  • Orthopedic Diseases
  • Infectious Diseases
By End User
  • Biopharmaceutical Companies and Pharmaceutical Companies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • CMIC Holdings Co Ltd
  • Axxelus
  • EPS Holdings Inc
  • MaBico
  • IQVIA Inc
  • Peak Pharma
  • QFR Solutions
  • Promoveo Health
  • Syneous Health Inc
  • Industry Developments and Future Opportunities:

    Various initiatives taken by key players operating in the global pharmaceutical contract sales organizations market are listed below:

    1. In September 2022, IQVIA, Inc. collaborated with pharmaceutical company Dr. Reddy's Laboratories. As per the arrangement, IQVIA provided Dr. Reddy's access to its Orchestrated Customer Engagement (OCE) platform to assist with its CRM operations. According to the partnership, Dr. Reddy's provided IQVIA's OCE application to all of its marketing users and field staff in India so they could more effectively engage customers by integrating marketing, account management, medical scientific liaison, sales, and other activities.
    2. In July 2021, ICON plc—a global provider of outsourced drug and device development and commercialization services to the pharmaceutical, biotechnology, medical device, and government and public health firms—acquired PRA Health Sciences, Inc. The merger enhances the consulting, clinical, and commercial services portfolio, geographic presence, therapeutic capabilities, and data-powered healthcare technology of the ICON, which aims to provide internationally scaled expertise and solutions.

    Competitive Landscape and Key Companies:

    CMIC Holdings Co Ltd, Axxelus Inc, EPS Holdings Inc, MaBico SA, IQVIA Holdings Inc, Peak Pharma Solutions Inc, QFR Solutions LLC, Promoveo Health LLC, Syneos Health Inc, and Mednext Pharmaceuticals Pvt Ltd are among the top pharmaceutical contract sales organizations. These companies focus on new technological services, advancements in existing services, and geographic expansions to meet the growing consumer demand worldwide.